Diagnostics Co. Sued After COVID-19 Test Revoked By FDA
Chembio Diagnostics Inc., a point-of-care diagnostics company that saw its stock price explode in the early stages of the coronavirus pandemic, was sued Thursday after authorization for its COVID-19 antibody test...To view the full article, register now.
Already a subscriber? Click here to view full article